Damora Therapeutics, Inc. · NASDAQ:DMRA
Venrock Healthcare Capital Partners III, L.P. reported a 6.00% stake in Damora Therapeutics, Inc. (Schedule 13G)
Event Feb 9, 2026 · Filed Feb 17, 2026
Venrock Healthcare Capital Partners III, L.P. reported a 6.00% stake in Damora Therapeutics, Inc., 3,603,595 shares, as a passive investor on Feb 9, 2026. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 3,603,595
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 6.00% | 3,603,595 |
| VHCP Co-Investment Holdings III, LLC | 6.00% | 3,603,595 |
| Venrock Healthcare Capital Partners EG, L.P. | 6.00% | 3,603,595 |
| VHCP Management III, LLC | 6.00% | 3,603,595 |
| VHCP Management EG, LLC | 6.00% | 3,603,595 |
| Nimish Shah | 6.00% | 3,603,595 |
| Bong Y. Koh | 6.00% | 3,603,595 |
Source
Related
- Damora Therapeutics, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Damora Therapeutics, Inc. shareholders
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026